ProPhase Labs, Inc. (PRPH) stock
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
Earnings
ProPhase Labs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of ProPhase Labs's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | Nov 19, 2025before the open | $900.00K | -71.0% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | $1.20M | -52.0% | -$0.11 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 20, 2025before the open | $1.40M | -61.1% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | $3.10M | – | -$0.35 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024before the open | $2.50M | – | -$0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | $3.60M | – | -$0.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 15, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023before the open | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 28, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 13, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 30, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 13, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 13, 2021during market hours | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Nov 16, 2020before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 11, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 14, 2020after the close | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 27, 2020before the open | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 12, 2019during market hours | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 12, 2019before the open | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 15, 2019during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period ProPhase Labs guided for has been reported
Guidance history
Every forecast ProPhase Labs put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 14, 2024 | pre-tax profit | next twelve months (Q3 2024 – Q2 2025) | $5.00M | – |
| Aug 14, 2024 | revenue | next twelve months (Q3 2024 – Q2 2025) | $14.00M – $16.00M | – |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases ProPhase Labs filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of ShareholdersUpdate
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Update
- Results
- News
- News
- News
- Results
See a number that looks wrong?